Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Florida | Superficial venous ablation · Texas | |
|---|---|---|
| Surgeons, 2024 | 243 | 220 |
| Medicare fee-for-service cases | 23,074 | 22,416 |
| Growth since 2019 (Medicare FFS) | −4.3%/yr | +0.2%/yr |
| Forecast cases (Medicare FFS) | 26,100 in 2030 | 30,300 in 2030 |
| Forecast growth | +2.1%/yr to 2030 | +5.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 9.8 | 9.9 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 100% (+1 pts since 2019) | 98% (−0 pts since 2019) |
| Cases per surgeon | 95 | 102 |
| Top 10 surgeons' share | 25% | 23% |
| Surgeons growing | 48 | 62 |
| New since the base year | 49 | 50 |
| Likely to stop billing it | 40 by 2026 | 23 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $374 | $404 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.